{"disease":{"id":"acneiform-eruption","name":"Acneiform eruption","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"sulfur","indication_name":"Acneiform eruption","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SULFUR","company_name":"Poythress","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 1","drug_class":"sulfur","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"resorcinol","indication_name":"Acneiform eruption","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"resorcinol","company_name":"","drug_phase":"unknown","molecular_target":"Carbonic anhydrase 12, Carbonic anhydrase 14, Carbonic anhydrase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05639933","title":"Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Hoth Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05919810","title":"The Effects of Oral Probiotics and Herbal Supplementation on the Gut Microbiome and Sebum Excretion Rate in Non-Cystic Acne","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Integrative Skin Science and Research","has_results":false},{"nct_id":"NCT03115567","title":"A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT05120362","title":"A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Shanghai East Hospital","has_results":false},{"nct_id":"NCT04697069","title":"A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Vanda Pharmaceuticals","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}